Abraham Ceesay's most recent trade in Pacira BioSciences Inc was a trade of 11,279 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Pacira BioSciences Inc | Abraham N. Ceesay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 11,279 | 11,279 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Abraham N. Ceesay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2025 | 6,163 | 11,393 (0%) | 0% | 0 | Common Stock | |
| Rapport Therapeutics Inc. | Abraham N. Ceesay | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Feb 2025 | 428,000 | 428,000 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Abraham N. Ceesay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 12,179 | 12,179 | - | - | Stock Option (Right to Buy) | |
| Pacira BioSciences Inc | Abraham N. Ceesay | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 12 Jun 2024 | 5,230 | 5,230 (0%) | 0% | 0 | Common Stock | |
| Rapport Therapeutics Inc. | Abraham N. Ceesay | Director, Chief Executive Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2024 | 530,647 | 530,647 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 114,445 | 114,445 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Feb 2023 | 29,083 | 29,083 | - | - | Restricted Stock Units | |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Sale of securities on an exchange or to another person at price $ 32.50 per share. | 08 Sep 2022 | 19,210 | 0 | - | 32.5 | 624,325 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Sep 2022 | 19,210 | 365,009 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 08 Sep 2022 | 19,210 | 19,210 | - | 13.2 | 252,996 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Sale of securities on an exchange or to another person at price $ 32.50 per share. | 22 Aug 2022 | 9,605 | 0 | - | 32.5 | 312,163 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 22 Aug 2022 | 9,605 | 384,219 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 22 Aug 2022 | 9,605 | 9,605 | - | 13.2 | 126,498 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Sale of securities on an exchange or to another person at price $ 34.12 per share. | 15 Aug 2022 | 9,606 | 0 | - | 34.1 | 327,757 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 15 Aug 2022 | 9,606 | 393,824 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 15 Aug 2022 | 9,606 | 9,606 | - | 13.2 | 126,511 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 05 Aug 2022 | 38,424 | 38,424 | - | 13.2 | 506,044 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 38,424 | 422,641 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Sale of securities on an exchange or to another person at price $ 32.50 per share. | 05 Aug 2022 | 38,424 | 0 | - | 32.5 | 1,248,780 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Aug 2022 | 19,211 | 403,430 | - | - | Stock Option (Right to Buy) | |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Exercise or conversion of derivative security received from the company (such as an option) at price $ 13.17 per share. | 05 Aug 2022 | 19,211 | 19,211 | - | 13.2 | 253,009 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Sale of securities on an exchange or to another person at price $ 37.75 per share. | 05 Aug 2022 | 9,606 | 9,605 | - | 37.8 | 362,627 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Sale of securities on an exchange or to another person at price $ 39.50 per share. | 05 Aug 2022 | 9,605 | 0 | - | 39.5 | 379,398 | Common Stock |
| Cerevel Therapeutics Holdi... | Abraham Ceesay | President | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 01 Jun 2021 | 461,065 | 461,065 | - | - | Stock Option (Right to Buy) |